Halberd Corporation’s VITA-Shield-MAX(TM) Immunity Support Products Transported
JACKSON Heart, PA / ACCESSWIRE / August 9, 2021 / Halberd Corporation (OTC PINK:HALB) reviews Vita-Protect-MaxTM, has been transported! With Covid-19 cases back on the increase fueled by the Delta Variant, this “Immunity Support Nutraceutical Item” is arriving at the right time.
William A. Hartman, Halberd’s Chairman, President & CEO, mentioned, “We will soon start out selling Vita-Protect-MaxTM and will be releasing details on paying for our solution in the near foreseeable future, as soon as we have the products in inventory.”
Halberd Corporation introduced a 120-webpage compilation of health care articles in aid of its VITA-Defend-MAXTM Nutraceutical product before.
To get the most current information on Halberd’s interesting developments, which includes our ongoing disorder eradication accomplishments, subscribe by submitting this variety.
(https://halberdcorporation.com/get in touch with-us/)
For far more details you should make contact with:
William A. Hartman
[email protected]
[email protected]
http://www.halberdcorporation.com
Twitter:@HalberdC
About Halberd Corporation.
Halberd Corporation (OTC PINK:HALB), is a publicly traded organization on the OTC Market, and is in full compliance with OTC Market reporting demands. It retains the unique around the world legal rights to numerous patent- and PCT-pending extracorporeal therapies for COVID-19 and other professional medical maladies: Halberd also holds the distinctive rights to the underlying granted U.S. Patent 9,216,386 and U.S. Patent 8,758,287.
Protected Harbor Detect
Selected statements contained herein are “forward-seeking statements” (as described in the Personal Securities Litigation Reform Act of 1995). The Corporations caution that statements, and assumptions made in this information launch constitute ahead-hunting statements and can make no assurance of upcoming performance. Ahead-seeking statements are based on estimates and views of management at the time statements are produced. These statements may possibly tackle issues that involve considerable threats, uncertainties, estimates produced by administration. Precise benefits could differ materially from present projections or implied outcomes. The Organizations undertake no obligation to revise these statements subsequent the date of this news launch.
Trader warning/included hazard for buyers in businesses saying involvement in COVID-19 initiatives –
On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the relevance of disclosure through the COVID-19 disaster.
The SEC and Self-Regulatory Companies are targeting public companies that assert to have products, treatment or other strategies with regard to COVID-19.
The greatest impact of the COVID-19 pandemic on the Firm’s operations is unknown and will depend on long term developments, which are hugely uncertain and can not be predicted with confidence, which includes the period of the COVID-19 outbreak. Moreover, new information and facts may arise relating to the severity of the COVID-19 pandemic, and any further preventative and protective actions that governments, or the Company, may perhaps direct, which may well result in an extended period of continued business enterprise disruption, decreased shopper website traffic and reduced operations. Any resulting monetary effect can’t be reasonably approximated at this time.
We further more warning investors that our major focus and intention is to fight this pandemic for the excellent of the planet. As these types of, it is achievable that we might locate it vital to make disclosures which are constant with that objective, but which may perhaps be adverse to the pecuniary passions of the Organization and of its shareholders.
Resource: Halberd Company
Look at resource version on accesswire.com:
https://www.accesswire.com/658881/Halberd-Organizations-VITA-Shield-MAXTM-Immunity-Help-Item-Delivered